Tuhu Auto ServicesOn May 30th, Tuhu Auto Services (Tuhu) officially signed a comprehensive cooperation agreement with Huawei Cloud. Earlier this year, Tuhu reached a cooperation agreement with Huawei to jointly promote new formats of digitalized after-sales service across all scenarios. They also reached the first cooperation on genuine traceability of automotive aftermarket parts with Huawei Cloud, providing genuine verification and anti-counterfeiting traceability for automotive parts in the circulation link. According to the agreement, Tuhu and Huawei Cloud will integrate their respective ecological resources to explore the best digital practices and joint solutions adapted to the automotive service industry, creating a healthy omni-channel value chain for the automotive aftermarket. Specifically, the two parties will launch the "one item, one code" solution, writing the full-chain circulation information of automotive parts into Huawei Cloud's blockchain to build a trusted supply chain traceability system across regions, industries, and enterprises. The automotive parts traceability platform supports scanning verification and anti-counterfeiting traceability of categories such as lubricants, tires, batteries, and maintenance parts, gradually achieving full coverage of popular categories and best-selling brands. The formal signing of the comprehensive cooperation agreement between the two parties undoubtedly sends a message to the industry: Tuhu's firm determination to ensure that the source of automotive parts is "traceable" and the quality is "reliable." This is also a significant positive development for the standardized development of the aftermarket.Yuanxin TechnologyOn April 9th, the Hurun Research Institute released the "2024 Global Unicorn List" in Guangzhou. The list includes non-listed companies founded after 2000 with a value of over $1 billion. Since 2021, Yuanxin Technology has been selected four times in the Hurun Research Institute's "Global Unicorn List," which is recognition and affirmation of Yuanxin Technology's sustainable development capabilities. In the future, Yuanxin Technology will continue to enhance its technological innovation capabilities and medical health service capabilities, providing patients with reliable, high-quality full-cycle medical health services to support the continuous development of the medical health industry. On May 24th, Chongqing Genrix Biopharmaceutical Co., Ltd. (Genrix Bio) and Yuanxin Technology held a strategic cooperation signing ceremony in Beijing. Genrix Bio is an innovative biopharmaceutical company (stock code: 688443) oriented towards clinical major needs, driven by antibody drug discovery technology. Focusing on the three major treatment areas of autoimmune diseases, infectious diseases, and tumors, the company continues to develop monoclonal antibody drugs and bispecific antibody drugs, achieving a full industry chain layout integrating research and development, production, and commercialization. In the future, the two parties will deepen cooperation in pharmaceutical services and accessible medication. FoF InvestmentOver the past three months, a number of portfolio companies of Starquest GPs' have completed the next round of financing in Technological Enterprise Services and Healthcare.Technological Enterprise ServicesZhenFund portfolio company Moffett AI, an AI chip designer, completed hundreds of millions of yuan in series B financing, led by Ant Group with Peakview Capital following. Gaorong Ventures portfolio company Design Order, an AI generative design and solution industrial product provider, completed series A+ financing, jointly led by Ameba Capital, Yonghua Capital, and existing shareholder Lenovo Capital. Gaorong Ventures and ZhenFund portfolio company Xtimes-da, an advanced digital implementation EDA solution provider, completed hundreds of millions of yuan in series B financing, jointly led by NRL Capital and Vertex Ventures China.HealthcareSherpa Healthcare Partners and Gaorong Ventures portfolio company Xi Soft-Tec, a digital intelligence solutions provider for healthcare operations management, completed series C financing, led by Shunwei Capital with SAIF Partners following. Industry RecognitionOn April 26, 2024, Outstanding and Outstanding Academy solemnly released the 4th Annual List of the Best Institutional LPs in China in 2023 at the "2024 China Institutional LP Conference". This list is based on data from 2023, relying on the contribution data from multiple institutional LPs behind the newly registered equity and venture capital funds in 2023 collected by Outstanding Academy. The selection process involved one-on-one targeted surveys and interviews with institutional LPs to identify the most active and outstanding LP institutions and individuals in 2023. Starquest Capital was awarded as "China TOP 20 Best Market LP in 2023". Meanwhile, Mr. Frankie Fang, the founding managing partner, and Mr. James Jin, the partner of Starquest Capital, were respectively honored as the "2023 Best Institutional LP Influential Figures TOP30" and the "2023 Best Institutional LP Elite Figures TOP30." ESG InsightIn June 2024, Starquest Capital published the latest ESG Investment Yearbook "The ESG Pathway 2023 - Diligence Leading the Future," which comprehensively analyzes and reveals the current development status and market trends of the global and Chinese responsible investment industry from the perspective of private equity investors. It also delves into evaluation methods and practical case studies.
5月 19 · 已讀1分鐘
